Boosting omega-3 fatty acid intake helps to preserve brain health and improve cognition in middle age, a new study reports. For those with the Alzheimer's associated APOE4 gene, omega-3 fatty acid intake was associated with greater hippocampal volume and less small vessel disease.
Two short cycles of a low-calorie diet that mimics fasting reduced inflammation and delayed cognitive decline in mouse models of Alzheimer's disease. Researchers report the diet is safe for humans and could help reduce signs of Alzheimer's.
Researchers have developed a simple behavioral test to measure an individual's risk of developing Alzheimer's disease before symptoms appear.
Researchers propose a new model for Alzheimer's disease (AD2) that considers the neurodegenerative disease as an autoimmune disease that attacks the brain. Considering Alzheimer's as an autoimmune disorder could spark a new line of therapies to treat the disease.
A new mortality prediction model for older patients with Alzheimer's disease can help medical professionals and families determine the best course of action for end-of-life care.
Researchers have devised a new, non-invasive method for tracking the progression of Alzheimer's disease. The study also proposes removing excess toxic Alzheimer's proteins from the blood could improve clinical symptoms and pathologies of Alzheimer's disease.
New research in cloned pigs with a mutation of the SORL1 sheds light on Alzheimer's development. The findings could pave the way for new treatments for the neurodegenerative disorder.
Two new studies strengthen the link between gum disease and the development of Alzheimer's disease. The studies focus on the interactions between the gingipains enzyme interacts with the Tau protein, and how the gingipains enzyme contributes to the development of amyloid-beta.
Mice with the Alzheimer's disease-associated APOE4 and the APOE2 genes were more likely to die from COVID-19 than those with the APOE3 gene. Those with APOE4 and APOE2 genes had more virus replication in the lungs, higher inflammation, and increased tissue damage following coronavirus infection.
Middle-aged people who experience at least one nightmare a week are four times more likely to experience cognitive decline during the following decade. Older adults who experience weekly nightmares are twice as likely to develop dementia. The association is much stronger for men than women.